Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared ACP-104 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimThis study evaluates the safety and effectiveness of NaBen® for people with schizophrenia.
This study ended early.
Multiple locations, including DothanThis study ended early.
Multiple locations, including Los Angeles
This study has finished and is no longer accepting participants.
In Munich
This study has finished and is no longer accepting participants.
In DallasAlpha-lipoic Acid Adjunctive Therapy in Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial
This study has finished and is no longer accepting participants.
In FortalezaThis study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Randomized, Open-label, Active-controlled Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In AnsanResearchers studied Paliperidone ER to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Antwerp
A Multicenter, Exploratory, Randomized, Double-Arm, 8-week Study to Evaluate the Feasibility and Acceptability of an Abbreviated Treatment with CT-156 in People with Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkA Single-Arm, Open Label, 16-week Extension Study to Evaluate the Efficacy and Safety of a Second Course of a Digital Therapeutic as an Adjunct to Standard of Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkResearchers studied SEP-363856, tracking side effects to assess safety and tolerability in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.